Revance loses attempt to dismiss Botox trade secrets lawsuitnews2024-01-04T20:11:30+00:00January 4th, 2024|Endpoints News|
FDA lifts partial clinical hold on Innate’s cancer drug after patient death linked to disease progressionnews2024-01-04T20:01:42+00:00January 4th, 2024|Endpoints News|
Bluebird snags more outcomes-based coverage for its $3M+ sickle cell gene therapynews2024-01-04T19:50:34+00:00January 4th, 2024|Endpoints News|
Lilly disavows use of Mounjaro, Zepbound for ‘cosmetic weight loss’news2024-01-04T19:49:47+00:00January 4th, 2024|Endpoints News|
Klick Health nabs award-winning creative director Tim Jones to lead team in Europenews2024-01-04T19:05:04+00:00January 4th, 2024|Endpoints News|
House Republicans call on FDA to hand over info on internal scientific disagreementsnews2024-01-04T18:48:27+00:00January 4th, 2024|Endpoints News|
Thermo Fisher to shutter Petaluma manufacturing facility, lay off 74 staffers by Februarynews2024-01-04T17:46:12+00:00January 4th, 2024|Endpoints News|
Scoop: Resilience receives Form 483 due to mold at Canadian site, more layoffs anticipatednews2024-01-04T17:35:30+00:00January 4th, 2024|Endpoints News|
Thermo Fisher extends Olink tender offer; Biogen and Ginkgo complete collab; WuXi signs biotech partner for ADCsnews2024-01-04T16:59:54+00:00January 4th, 2024|Endpoints News|
AbbVie taps Umoja for new in vivo CAR-T dealnews2024-01-04T16:16:47+00:00January 4th, 2024|Endpoints News|
